Design Therapeutics, Inc. (DSGN)

NASDAQ

$10.65

$+0.43

(+4.17%)

Regular Market

Design Therapeutics, Inc. (DSGN) Live Price Chart

Last updated: ⁦2026-10-19 19:59:40⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Design Therapeutics, Inc. (DSGN) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $10.65, with a market capitalization of $645.22M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $5.28 to $17.25. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$645.22M
Open	$10.42
Day's High	$50.50
Day's Low	$1.94
Previous Close	$10.31
Volume	274.32K
Average Volume	606.13K
P/E Ratio	--
52-Week High	$17.25
52-Week Low	$5.28
Dividend Yield	--
Earnings Date	--

Design Therapeutics, Inc. (DSGN) Stock Price Today

Design Therapeutics, Inc. (DSGN) is currently trading at $10.65 as of 2026-10-19 19:57:00, up 3.30% ($0.34) from the previous close of $10.31

During today's regular trading session, DSGN has traded between $1.94 and $50.50, with a trading volume of 274.32K shares. The current price is near the lower end of today's range.

Design Therapeutics, Inc. (DSGN) 7-Day Stock Price Change

Over the past seven days, Design Therapeutics, Inc. (DSGN) moved from $11.49 to $10.65, representing a decline of 7.31% ($0.84).

The stock traded between $9.48 and $11.92 during the period. The latest price is near the middle of the 7-day range, indicating strong downward.

The average daily volume was 638.35 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

DSGN 52-Week Price Position

Position in Range: 44.9%

52W Low$5.28

52W High$17.25

DSGN is currently trading at $10.65, placing it 44.9% of the way from its 52-week low of $5.28 to its 52-week high of $17.25. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Design Therapeutics, Inc. (DSGN)?

Design Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the research and development of GeneTAC molecules, which are a novel class of small-molecule gene targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations. Its pipeline includes Friedreich Ataxia, FECD, DM1, and Huntington's Disease. The company operates in one operating and reportable segment focused on utilizing the company's proprietary GeneTAC platform to design and develop therapeutic candidates for inherited diseases driven by nucleotide repeat expansion.

Design Therapeutics, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	55
Exchange	NASDAQ
Company Website	https://www.designtx.com

How to Buy Design Therapeutics, Inc. (DSGN) Stock on MEXC

Eligible investors can buy real shares of Design Therapeutics, Inc. (DSGN) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for DSGN and Place Your Order

Open the RealStocks trading page and search for DSGN. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Design Therapeutics, Inc. (DSGN) stock price today?

Design Therapeutics, Inc. (DSGN) is currently trading at $ 10.65, up 3.30% ($0.34) from the previous close of $ 10.31. Intraday prices update in real time during regular trading hours.

2.Is DSGN stock going up or down today?

As of 2026-10-19 19:57:00, DSGN is trading at $ 10.65, up 3.30% ($0.34) from its previous close of $ 10.31. The stock has traded between $ 1.94 and $ 50.50 during today’s regular session. Past price movements do not guarantee future results.

3.What is DSGN pre-market price?

As of 2026-10-19 19:57:00, DSGN is trading at $ 10.15 in pre-market trading, down 1.54% ($0.16) from the previous close of $ 10.31. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is DSGN after-hours price?

As of 2026-10-19 19:57:00, DSGN is trading at $ 10.30 in after-hours trading, down 0.10% ($0.01) from the regular-session close of $ 10.31. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is DSGN stock trading now?

DSGN trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does DSGN sit relative to its 52-week high and low?

Over the past 52 weeks, DSGN has traded between a low of $ 5.28 and a high of $ 17.25. At $ 10.65, the stock is positioned 44.9% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Design Therapeutics, Inc. in?

Design Therapeutics, Inc. (DSGN) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Design Therapeutics, Inc.'s market capitalization and where is it listed?

Design Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 645.22M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is DSGN valued in terms of P/E ratio and EPS?

DSGN trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -1.13. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Design Therapeutics, Inc. pay a dividend?

Design Therapeutics, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.